Regulatory Story
Go to market news section View chart   Print
Northamber PLC   -  NAR   

Transaction in Own Shares

Released 17:00 04-Mar-2020

RNS Number : 0430F
Northamber PLC
04 March 2020

4 March 2020


Northamber PLC

("Northamber" or the "Company")


Transaction in Own Shares and interim dividend timetable


Northamber (AIM: NAR) announces that today it purchased 100,000 of its 1p ordinary shares at an average price paid per share of 68p.


The number of shares purchased represented 0.36% of the voting rights attributable to the total ordinary shares in issue prior to such purchase.


The 100,000 ordinary shares which have been purchased today, in addition to the 25,000 ordinary shares already held in treasury will be cancelled. Therefore, the total number of ordinary shares carrying voting rights will be 27,231,586.


Total voting rights


The figure of 27,231,586 ordinary shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.


Individual transactions


In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the individual purchases made by Cantor Fitzgerald on behalf of the Company.


Number of shares purchased

Transaction price (pence per share)

Execution venue






Interim dividend timetable


The Company also wishes to clarify its interim dividend timetable is as follows:


Ex-dividend date:                            16 April 2020


Record date:                                     17 April 2020


Payment date:                                 15 May 2020



For more information, please contact:



Cantor Fitzgerald Europe (Nominated Adviser & Broker)

020 7894 7000

Phil Davies / Michael Boot







This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


Transaction in Own Shares - RNS